Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic effects on cardiac remodeling.

Norman Sharpe1

  • 1n.sharpe@auckland.ac.nz

Current Heart Failure Reports
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Cardiac remodeling is key in heart failure progression and impacts patient outcomes. Targeting neurohormonal systems with combination therapy improves cardiac remodeling and clinical results, becoming standard care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The National Heart Foundation of New Zealand: reviewing the past, the present and future challenges.

Heart, lung & circulation·2015
Same author

Rheumatic fever: from disease targeting to child-centredness.

The New Zealand medical journal·2012
Same author

Rheumatic fever in New Zealand: from perennial failure to successful eradication.

The New Zealand medical journal·2011
Same author

New Zealand's shocking diabetes rates can be reduced--9 urgently needed actions.

The New Zealand medical journal·2011
Same author

Inequities in health and the Marmot Symposia: time for a stocktake.

The New Zealand medical journal·2011
Same author

Once-daily amoxicillin for Group A Streptococcal (GAS) sore throat as the other first-line option: a clarification of the NZ sore throat guidelines.

The New Zealand medical journal·2011

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Outcomes

Background:

  • Cardiac remodeling is a fundamental mechanism driving heart failure progression.
  • Changes in cardiac remodeling strongly correlate with long-term patient outcomes.
  • Cardiac remodeling serves as both a therapeutic target and a surrogate for clinical endpoints.

Purpose of the Study:

  • To highlight the significance of cardiac remodeling in heart failure.
  • To emphasize the role of neurohormonal blockade in managing heart failure.
  • To advocate for standardizing specific combination treatments.

Main Methods:

  • Review of clinical research over several decades.
  • Analysis of the relationship between cardiac remodeling and clinical outcomes.

Related Experiment Videos

  • Evaluation of neurohormonal blockade therapies.

    • Main Results:

    • Cardiac remodeling is intrinsically linked to heart failure progression and clinical outcomes.
    • Combination treatments targeting the renin-angiotensin-aldosterone and sympathetic systems effectively improve cardiac remodeling.
    • These neurohormonal blockade strategies enhance clinical outcomes in heart failure patients.

    Conclusions:

    • Cardiac remodeling is a critical factor in heart failure and a valuable surrogate for outcomes.
    • Neurohormonal blockade, combining therapies against renin-angiotensin-aldosterone and sympathetic systems, is effective.
    • Standardizing this combination therapy is recommended for patients with left ventricular dysfunction post-myocardial infarction and chronic heart failure.